Table 2.
Anthropometric, thyroid, and metabolic characteristics in PCOS women in accordance with nutritional status. Each of the 3 groups untreated SCH, treated SCH, and control group was divided into two subgroups: patients with normal BMI (BMI <25) and patients with overweight/obesity (BMI ≥25).
| Variable | Group | |||||
|---|---|---|---|---|---|---|
| Non-treatment | Treatment | Control | ||||
| Normal BMI n = 21 | BMI ≥25 n = 17 | Normal BMI n = 32 | BMI ≥25 n = 44 | Normal BMI n = 49 | BMI ≥25 n = 27 | |
| Age (years) | 24.57 ± 3.93 | 23.76 ± 4.56 | 25.06 ± 4.20 | 25.36 ± 4.39 | 24.53 ± 3.48 | 25.30 ± 4.63 |
| BMI (kg/m2) | 21.25 ± 2.07 | 32.25 ± 6.08 | 21.51 ± 2.15 | 31.20 ± 3.28 | 21.18 ± 1.71 | 32.07 ± 5.91 |
| TSH (mIU/L) (0.27–4.2) | 5.29 ± 1.23 | 5.93 ± 1.85 | 1.94 ± 0.89 | 2.20 ± 0.94 | 1.68 ± 0.52 | 1.50 ± 0.90 |
| CHOL (mmol/l) (<5.2) | 4.56 ± 0.67 | 5.3 ± 1.04 | 4.71 ± 0.97 | 4.82 ± 0.86 | 4.71 ± 0.77 | 4.74 ± 1.06 |
| HDL-C (mmol/l) (>1) | 1.48 ± 0.42 | 1.2 ± 0.26 | 1.49 ± 0.3 | 1.19 ± 0.29 | 1.63 ± 0.39 | 1.63 ± 0.39 |
| LDL-C (mmol/l) (<3.4) | 2.56 ± 0.49 | 3.4 ± 1.08 | 2.77 ± 0.76 | 2.9 ± 0.76 | 2.63 ± 0.64 | 3.02 ± 0.85 |
| TRIG (mmol/l) (<1.7) | 1.17 ± 0.6 | 1.5 ± 0.51 | 0.97 ± 0.45 | 1.59 ± 0.64 | 1.01 ± 0.4 | 1.45 ± 1.06 |
| Glucose (mmol/l) (4.08–5.84) | 4.7 ± 0.27 | 4.9 ± 0.41 | 4.71 ± 0.38 | 5.0 ± 0.36 | 4.69 ± 0.57 | 5.08 ± 0.88 |
| Insulin [uIU/ml] (<24) | 7.19 ± 3.38 | 15.89 ± 7.94 | 7.25 ± 3.55 | 12.70 ± 6.40 | 7.02 ± 2.59 | 13.84 ± 11.45 |
| HOMA-IR | 1.52 ± 0.71 | 3.51 ± 1.87 | 1.54 ± 0.80 | 2.88 ± 1.55 | 1.49 ± 0.61 | 3.23 ± 2.63 |
BMI, body mass index; CHOL, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, light-density lipoprotein cholesterol; TRIG, triglycerides; HOMA-IR, homeostatic assessment of insulin resistance.